Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00551/full |
id |
doaj-b802d4b3f45e4e0bb4a1390007f95a35 |
---|---|
record_format |
Article |
spelling |
doaj-b802d4b3f45e4e0bb4a1390007f95a352020-11-25T00:10:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-06-01910.3389/fonc.2019.00551463198Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?Eric D. Brooks0Vivek Verma1Joe Y. Chang2Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United StatesDepartment of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, United StatesDepartment of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United Stateshttps://www.frontiersin.org/article/10.3389/fonc.2019.00551/fullmissilelung cancerNSCLCSBRTpathologic complete responsePCR |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eric D. Brooks Vivek Verma Joe Y. Chang |
spellingShingle |
Eric D. Brooks Vivek Verma Joe Y. Chang Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? Frontiers in Oncology missile lung cancer NSCLC SBRT pathologic complete response PCR |
author_facet |
Eric D. Brooks Vivek Verma Joe Y. Chang |
author_sort |
Eric D. Brooks |
title |
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
title_short |
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
title_full |
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
title_fullStr |
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
title_full_unstemmed |
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC? |
title_sort |
does pathologic response equate to clinical response following sabr for early-stage nsclc? |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2019-06-01 |
topic |
missile lung cancer NSCLC SBRT pathologic complete response PCR |
url |
https://www.frontiersin.org/article/10.3389/fonc.2019.00551/full |
work_keys_str_mv |
AT ericdbrooks doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc AT vivekverma doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc AT joeychang doespathologicresponseequatetoclinicalresponsefollowingsabrforearlystagensclc |
_version_ |
1725406615323017216 |